High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity
- 20 August 2005
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 20 (12) , 1744-1749
Abstract
Cyclosporin A (CsA) is an effective treatment for frequently relapsing steroid-dependent nephrotic syndrome (FR-SDNS), but its use can be complicated by renal toxicity and a high incidence of relapses after withdrawal. We report 9 adolescent patients with childhood-onset FR-SDNS who had been treated with long-term CsA that resulted in moderate-to-severe CsA nephropathy (CsAN). They were treated with high-dose (mean: 10.1 mg/kg per day) mizoribine (MZR) in an attempt to allow weaning of CsA and/or steroid therapy, and reduce the frequency of relapses. Seven out of 9 patients were weaned off CsA by 1-year follow-up, although in the remaining 2 patients, MZR did not show any beneficial effects. Overall, this high-dose MZR therapy results in significant steroid sparing and reduction in relapse rates in our patients. Our experience shows that high-dose MZR therapy in patients with FR-SDNS who are also CsA-dependent appears to be effective in reducing CsA exposure as well as in decreasing the frequency of relapses.Keywords
This publication has 23 references indexed in Scilit:
- Mizoribine oral pulse therapy for steroid-dependent nephrotic syndromePediatric Nephrology, 2004
- Mizoribine oral pulse therapy for patients with disease flare of lupus nephritisClinical Nephrology, 2003
- Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndromePediatric Nephrology, 2003
- Immunosuppressive agents in childhood nephrotic syndrome: A meta-analysis of randomized controlled trialsKidney International, 2001
- A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndromeKidney International, 2000
- Functional Interaction of the Immunosuppressant Mizoribine with the 14-3-3 ProteinBiochemical and Biophysical Research Communications, 2000
- A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1996
- Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine.Journal of Clinical Investigation, 1991
- IMMUNOSUPPRESSIVE EFFECT OF BREDININ ON CELL-MEDIATED AND HUMORAL IMMUNE REACTIONS IN EXPERIMENTAL ANIMALSTransplantation, 1983
- Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosisKidney International, 1978